Strata Critical Medical, Inc.
SRTA
$6.03
$0.091.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 66.75% | 74.15% | 34.28% | 5.60% | -20.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.75% | 74.15% | 34.28% | 5.60% | -20.58% |
| Cost of Revenue | 62.79% | 73.91% | 34.61% | 7.83% | -17.61% |
| Gross Profit | 84.09% | 75.10% | 32.97% | -2.67% | -31.39% |
| SG&A Expenses | -2.96% | 26.22% | 3.79% | -2.61% | -11.37% |
| Depreciation & Amortization | 430.02% | 166.87% | 167.73% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.98% | 61.48% | 26.00% | 4.29% | -16.19% |
| Operating Income | 61.88% | 36.87% | 31.61% | 4.83% | -20.46% |
| Income Before Tax | -28.11% | -19.30% | -24.16% | 49.40% | 51.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.11% | -18.56% | -24.16% | 48.19% | 50.82% |
| Earnings from Discontinued Operations | 7,103.31% | 11,141.33% | 4,588.02% | 1,601.47% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 311.88% | 276.90% | 251.42% | 178.49% | 61.43% |
| EBIT | 61.88% | 36.87% | 31.61% | 4.83% | -20.46% |
| EBITDA | 119.81% | 83.55% | 51.70% | -1.10% | -34.95% |
| EPS Basic | 306.85% | 267.80% | 242.46% | 170.68% | 63.35% |
| Normalized Basic EPS | 79.43% | 65.18% | 61.20% | -12.13% | -156.65% |
| EPS Diluted | 301.89% | 266.78% | 239.88% | 169.60% | 62.68% |
| Normalized Diluted EPS | 79.43% | 65.18% | 61.20% | -12.13% | -155.56% |
| Average Basic Shares Outstanding | 6.58% | 6.57% | 6.23% | 5.52% | 5.43% |
| Average Diluted Shares Outstanding | 8.11% | 8.12% | 6.23% | 5.52% | 3.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |